SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,660 | +87.1% | 27,000 | +255.9% | 0.00% | – |
| Q3 2022 | $297,000 | +42.1% | 7,586 | +20.4% | 0.00% | – |
| Q1 2022 | $209,000 | -95.1% | 6,300 | -91.6% | 0.00% | -100.0% |
| Q2 2021 | $4,278,000 | +191.0% | 75,300 | +213.1% | 0.00% | +300.0% |
| Q3 2020 | $1,470,000 | -51.8% | 24,051 | +10.7% | 0.00% | -66.7% |
| Q3 2019 | $3,047,000 | -29.0% | 21,723 | -7.3% | 0.00% | -40.0% |
| Q2 2019 | $4,289,000 | -71.9% | 23,424 | -75.5% | 0.01% | -70.6% |
| Q1 2019 | $15,237,000 | +275.9% | 95,800 | +126.4% | 0.02% | +183.3% |
| Q4 2018 | $4,053,000 | +28.0% | 42,313 | +88.7% | 0.01% | +50.0% |
| Q3 2018 | $3,167,000 | +451.7% | 22,421 | +511.8% | 0.00% | +300.0% |
| Q2 2018 | $574,000 | -87.6% | 3,665 | -87.3% | 0.00% | -83.3% |
| Q1 2018 | $4,637,000 | +78.7% | 28,794 | +82.8% | 0.01% | +100.0% |
| Q4 2017 | $2,595,000 | -16.9% | 15,754 | -68.6% | 0.00% | -40.0% |
| Q3 2017 | $3,121,000 | -26.1% | 50,100 | -5.5% | 0.01% | -37.5% |
| Q2 2017 | $4,221,000 | +510.9% | 52,996 | +253.3% | 0.01% | +700.0% |
| Q3 2016 | $691,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |